Amiodarone inhibits tissue factor expression in monocytic THP-1 cells

Area of Science:

• Cardiovascular Pharmacology
• Cellular Biology
• Thrombosis Research

Background:

• Thrombus formation is implicated in sudden cardiac death.
• Amiodarone, a potassium channel inhibitor, reduces mortality and exhibits antithrombotic actions.
• Tissue factor plays a critical role in the coagulation cascade and thrombosis.

Purpose of the Study:

• To investigate the effect of amiodarone on tissue factor (TF) mRNA and protein expression in human monocytic THP-1 cells.
• To explore the role of specific potassium channels (Kv1.3 and Kir2.1) in amiodarone's effect on TF expression.
• To elucidate the mechanism behind amiodarone's antithrombotic properties.

Main Methods:

• Human monocytic THP-1 cells were treated with tumor necrosis factor-α (TNF-α) to induce tissue factor expression.
• The impact of amiodarone, margatoxin (Kv1.3 blocker), and Ba(2+) (Kir2.1 blocker) on TF mRNA and protein levels was assessed.
• Dose-dependency and comparative inhibitory effects were analyzed.

Main Results:

• Amiodarone (10μM) almost completely inhibited TNF-α-induced tissue factor mRNA and protein expression in a dose-dependent manner.
• Margatoxin significantly inhibited TF protein but not mRNA expression.
• Ba(2+) partly inhibited both TF mRNA and protein expression.
• Amiodarone's inhibitory effects were more potent than those of margatoxin and Ba(2+).

Conclusions:

• Amiodarone inhibits tissue factor expression in monocytic cells primarily by suppressing mRNA transcription.
• This mechanism provides a novel explanation for amiodarone's potent antithrombotic actions, particularly in conditions promoting thrombus formation.
• Amiodarone exhibits a distinct and potent inhibitory mechanism on tissue factor expression beyond Kv1.3 and Kir2.1 channel blockade.